Impact of Progression of Parkinson's Disease and Various Other Factors on Generalized Anxiety Disorder
| Autor: | Eraad Rahman, Hamza Ansari, Abdul Rehman M. Qureshi, Abdul Qayyum Rana |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2018 |
| Předmět: |
Generalized anxiety disorder
Parkinson's disease Movement disorders Disease Anxiety 050105 experimental psychology lcsh:RC321-571 Odds Parkinson's disease stage 03 medical and health sciences 0302 clinical medicine gender Medicine 0501 psychology and cognitive sciences lcsh:Neurosciences. Biological psychiatry. Neuropsychiatry Depression (differential diagnoses) business.industry General Neuroscience 05 social sciences Confounding medicine.disease Original Article Neurology (clinical) medicine.symptom business 030217 neurology & neurosurgery Clinical psychology |
| Zdroj: | Journal of Neurosciences in Rural Practice Journal of Neurosciences in Rural Practice, Vol 09, Iss 03, Pp 287-290 (2018) |
| ISSN: | 0976-3155 0976-3147 |
| Popis: | Objective: While much research has been conducted toward understanding the relationship between prevalence of Parkinson's disease (PD) and generalized anxiety, little has been done considering additional influential factors in the relationship by means of a large ethnically diverse sample. Our study strives to fulfill these deficits in the literature as we set out to determine the impact of progression of PD, age, gender, and Hoehn and Yahr (H and Y) staging of PD on generalized anxiety. Methods: A retrospective chart review analysis was performed on PD patients who were regularly examined in a community-based PD and movement disorders center from 2005 to 2010. Results: This study consisted of 310 patients with PD among whom 12% had generalized anxiety. Neither age nor gender was significant onset predictors at P = 0.05. The impact of progression of H and Y Stages 2–3 and 2–4 increased the odds of generalized anxiety disorder (GAD) prevalence though it was statistically insignificant at P = 0.05. Conclusions: Clinicians should not expect the risk of developing anxiety to depend on gender nor change as a function of age though it may increase with symptomatic progression of PD as outlined by H and Y. To the best of our knowledge, this is the largest and most ethnically diverse prevalence study with a focus on generalized anxiety and PD. Significant Outcomes and Limitations: The symptomatic progression of PD, but not age or gender, may be associated with an increased risk for GAD. This study lacked adjustment for potential confounders such as depression and PD medications. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
| Nepřihlášeným uživatelům se plný text nezobrazuje | K zobrazení výsledku je třeba se přihlásit. |